8am CEO Dru Armstrong shares how ChatGPT helped decode complex cancer data

Dru Armstrong, the CEO of the rapidly expanding tech company 8am, faced a daunting personal challenge this year when she was diagnosed with Stage II breast cancer. Despite being younger than the typical patient and lacking genetic risk factors, Armstrong turned to ChatGPT to help her decipher intricate pathology and genomic reports. The AI tool provided her with the confidence she needed to engage in informed, data-driven conversations with her medical team, ultimately aiding her in making critical treatment decisions. Her journey sheds light on a concerning trend: breast cancer rates are rising most sharply among women under 50, particularly in cases like hers that are hormone receptor-positive. Balancing her demanding role, which oversees over 600 employees and boasts a staggering 217 percent revenue growth, Armstrong reflects on how her busy schedule led her to delay routine screenings, a choice she now deeply regrets. Approaching her cancer treatment with the same determination she applies in her business, Armstrong acted swiftly. She expedited necessary appointments, biopsies, and scans, managing to undergo surgery and begin chemotherapy within just 60 days of her diagnosis. "Nobody was going to save me except myself," she stated, highlighting the vital role of self-advocacy in both healthcare and business. Incorporating practices that were once seen as optional, such as acupuncture and lymphatic drainage, became crucial to her recovery. Armstrong emphasizes that self-care should be viewed as an essential component of maintaining one’s health and performance, rather than merely a luxury. Throughout her treatment, Armstrong has openly acknowledged the importance of relying on her support network of friends, family, and colleagues, especially during the taxing chemotherapy sessions. By delegating responsibilities at work, she has been able to focus on her treatment without hindering her company's progress. ChatGPT emerged as an indispensable ally in her medical journey, helping her interpret complex data and evaluate treatment options. Now halfway through her chemotherapy, she continues to juggle her work, family, and recovery, demonstrating the significant role technology can play in critical health decisions.